Context: Obesity has been shown to be unfavorable to skeletal microarchitecture when assessed by trabecular bone score (TBS). The influence of adiposity on skeletal microstructure in primary hyperparathyroidism (PHPT) has not yet been evaluated.
T rabecular bone score (TBS) is an indirect measure of bone microarchitecture that is derived from a textural analysis of pixel gray level variations in dual-energy Xray absorptiometry (DXA) images of the lumbar vertebrae (1) . TBS quantification is readily determined from software applied to the DXA image. It has become a convenient clinical tool to estimate skeletal microarchitecture (2) . Better bone quality in vertebrae with dense trabeculae and good connectivity is reflected as a more homogenous pixel variation and a higher TBS, whereas poor bone quality with more disconnected trabeculae is reflected as a more heterogeneous pixel variation and a lower score (1, 3) . TBS values have been shown to correlate with fracture risk, independent of bone mineral density (BMD) (4, 5) .
Both vertebral and nonvertebral fracture risk are increased in primary hyperparathyroidism (PHPT) (6) (7) (8) . Prior studies have shown that TBS values in PHPT are significantly lower than matched controls. Moreover, TBS assessment was shown to discriminate between patients with and without vertebral fractures (9, 10) . The influence of adiposity on skeletal microstructure in PHPT is of interest because parathyroid hormone (PTH) influences osteoblast and adipocyte lineages through a common mesenchymal stem cell progenitor (11) . Although TBS is inversely related to body mass index (BMI) in subjects without PHPT, whether a relationship exists in PHPT and/or differs from what has been described among normal subjects is not known. Moreover, if there are differences in TBS among normal and obese subjects with PHPT, it is not known if such differences are affected by curative parathyroidectomy. In this study, we examined TBS in obese and nonobese subjects with PHPT at baseline and prospectively 2 years after parathyroid surgery.
Materials and Methods

Patients
Thirty subjects with well-characterized PHPT undergoing parathyroidectomy were recruited from the Metabolic Bone Diseases Unit at Columbia University Medical Center (CUMC). Subjects were eligible if they had biochemical evidence of PHPT (hypercalcemia with elevated or inappropriately normal PTH) with at least 6 months of follow-up after surgery. Exclusion criteria included a clinical diagnosis of any chronic disorder affecting mineral metabolism such as Paget disease of bone, untreated thyroid disease, Cushing syndrome, diabetes mellitus, malabsorption syndrome, liver disease, renal disease (creatinine clearance ,30 mL/min), current or recent pregnancy, or lactation. Current users of bisphosphonates or denosumab were also excluded as were subjects with a BMI .37 kg/m 2 or ,15 kg/m 2 . The cohort was grouped according to World Health Organization's definition of obesity into two subgroups: BMI $30 kg/m 2 (obese) and BMI ,30 kg/m 2 (nonobese). The study was approved by the Institutional Review Board of CUMC. Of the 30 subjects with baseline data, 25 participants (10 obese and 15 nonobese) had bone density and TBS measurements at 6 months, 28 participants (9 obese and 19 nonobese) at 12 months, 20 participants (7 obese and 13 nonobese) at 18 months, and 20 participants (9 obese and 11 nonobese) at 24 months.
Biochemical evaluation
Blood samples were drawn in a fasting state. Serum total calcium and albumin were analyzed using standard methods (Quest Diagnostics, Madison, NJ). Calcium values were corrected for low albumin (albumin ,4.0 g/dL) using the standard equation: corrected calcium = [0.8 3 (4.0 2 patient's albumin)] + serum calcium level. Intact PTH was measured by immunoradiometric assay (Scantibodies, Santee, CA) in the Bone Marker Laboratory of the Metabolic Bone Diseases Unit at CUMC. The normal range was 14 to 66 pg/mL, and the interassay and intraassay coefficients were ,7% and 5%, respectively. Propeptide of type I collagen (P1NP) was measured by immunoradiometric assay (Immunodiagnostic Systems, Scottsdale, AZ). The normal premenopausal range is 19 to 83 mg/L, and the interassay and intraassay coefficients of variation were 8.3% and 6.5%, respectively. Collagen type 1 cross-linked C-telopeptide (CTX) was measured by enzymelinked immunosorbent assay (Immunodiagnostic Systems). The normal premenopausal range is 0.112 to 0.738 ng/mL, and interassay and intraassay coefficients of variation were 10.9% and 3%, respectively.
BMD
Areal BMD was measured at the lumbar spine (L1 to L4), total hip, femoral neck, and nondominant forearm by DXA (Hologic 4500A; Hologic Inc., Bedford, MA). Short-term, in vivo, precision error was 1.1% for L1 to L4, 2.4% for total hip and femoral neck, and 1.8% for the forearm. As the cohort consisted of premenopausal women and men ,50 years of age, both absolute values as well as Z-scores for BMD (using sexand age-matched reference data provided by the manufacturer) and T scores for BMD are presented.
TBS
TBS values were classified into three categories as follows (4, 12, 13) : #1.2 (fully degraded microarchitecture); 1.21 to 1.34 (partially degraded microarchitecture); and $1.35 (normal). TBS was calculated from the L1 to L4 DXA image (Hologic Inc.) using TBS iNsight®, version 2.1 software (Med-Impas, Pessac, France). This newer software has an updated algorithm that adjusts for abdominal soft tissue based on BMI and is optimized for BMI within 15 to 37 kg/m 2 (14) .
Statistical analysis
Histograms were used to assess the normality of the distribution for continuous variables. The x 2 test or Fisher exact test was used for between-group comparisons for categorical variables and independent t tests for between-group comparisons for continuous variables. A linear mixed-effect model for repeated-measures approach was used for within-group comparisons of skeletal variables longitudinally across all time points (baseline and 6, 12, 18, and 24 months following surgery) for the entire cohort and the obese and nonobese subgroups. The correlation of TBS with BMI was assessed by the Pearson correlation test. All statistical tests were two-tailed, and a P ,0.05 was considered significant. The statistical software R version 3.2 (http://www.r-project.org/) and SPSS 23.0 for Windows (IBM Corp., Armonk, NY) were used for the analyses. The data are presented as mean 6 standard deviation (SD) for continuous variables unless otherwise stated. Data for categorical variables are presented as frequency and percentage.
Results
Demographic and biochemical indices
The baseline characteristics of the study population are shown in Table 1 . The cohort (n = 30) was predominantly female (70.0%), with a mean age of 62.9 6 12 years, consistent with the demographics of the disease. The majority were non-Hispanic white women (86.7%). On average, subjects had mild disease with mean corrected serum calcium 10.4 6 0.6 mg/dL, mean serum PTH 90.6 6 47 pg/mL, and mean serum 25-hydroxyvitamin D 45.7 6 15 ng/mL. The majority (86.7%) of the study population met one or more surgical guidelines for parathyroidectomy (15) . The obese group (n = 10) had a BMI of 33.4 6 3 kg/m 2 and was significantly heavier than the nonobese group (n = 20; 24.3 6 4 kg/m 2 ; P = 0.001). There were no noteworthy differences in age, sex, ethnicity, menopausal status, duration of disease, serum PTH, calcium, phosphate, vitamin D status, renal function, or bone turnover markers between groups at baseline. In addition, there were no differences in the history of fractures, prior history of bisphosphonate use, or proportion of subjects meeting criteria for parathyroidectomy between the two groups. All subjects had persistently normal serum calcium values postparathyroidectomy, demonstrating biochemical cure.
BMD
At baseline, lumbar spine BMD (g/cm 2 ) and Z-scores were normal in both the obese (BMD 0.936 6 0.19 g/cm 2 ; Z-score 0.13 6 1.9; T-score 21.24 6 1.8) and nonobese subjects (BMD 0.939 6 0.15 g/cm 2 ; Z-score 0.31 6 1.5; T-score 21.07 6 1.4) and were not significantly different between the two groups ( Table 1) . After parathyroidectomy, there was a marked improvement in lumbar spine BMD in the nonobese group noted at 6 months and obese group at 12 months that persisted through 24 months [ Fig. 1(b) ]. The improvement in lumbar spine BMD was similar between the obese and nonobese groups. At 24 months, there was a 4.3 6 5% increase in the obese group and a 3.8 6 6% increase in the nonobese group (P = 0.813) ( Table 2) . Z-score 20.35 6 0.8; T-score 21.64 6 0.7) at baseline ( Table 1) . After parathyroidectomy, there was an improvement in femoral neck BMD at 12 months in the nonobese group and an improvement at 18 months in the obese group. There were no significant between-group differences. At 24 months, there was a 3.8 6 7% increase in femoral neck BMD in the obese group and a 3.1 6 5% increase in the nonobese group (P = 0.960) ( Table 2 ). Of note, there was a 6-month delay in BMD improvement among the obese as compared with the nonobese at the lumbar spine and femoral neck. Total hip BMD and Z-scores in the obese subjects (BMD 0.847 6 0.15 g/cm 2 ; Z-score 20.00 6 1.1;
T-score 20.98 6 1.1) were not significantly different from the nonobese subjects (BMD 0.819 6 0.12 g/cm 2 ;
Z-score 20.17 6 0.8; T-score 21.15 6 0.8) at baseline (Table 1 ). After parathyroidectomy, there was an improvement in total hip BMD at 6 months in both the obese and nonobese groups. There were no noteworthy between-group differences. At 24 months, there was a 4.3 6 4% increase in total hip BMD in the obese group and a 2.8 6 5% increase in the nonobese group (P = 0.629) ( Table 2) . Baseline distal radius BMD and Z-scores in the obese group (BMD 0.633 6 0.11 g/cm 2 ; Z-score 20.39 6 1.7; T-score 21.89 6 1.6) were also not different from the nonobese group (BMD 0.638 6 0.09 g/cm 2 ; Z-score +0.08 6 1.3; T-score 21.42 6 0.5) ( Table 1) . Following parathyroidectomy, there were no notable differences in BMD in either the obese or nonobese groups.
TBS
At baseline, the mean TBS in the obese group reflected a fully degraded microarchitectural classification (1.199 6 0.09) and was significantly lower than the value in the nonobese group, which showed a minimally degraded microarchitecture classification (1.327 6 0.10; P = 0.003) (Fig. 2) . After parathyroidectomy, there were no notable differences from baseline for the study population as a whole or for the obese and nonobese subgroups [ Fig. 1(a) ]. However, the mean TBS value remained significantly lower in the obese group than the nonobese group throughout the 24 months. There was an inverse relationship between TBS and BMI using baseline values (r = 20.476; P = 0.009).
Effect of age on BMD and TBS
Using a linear mixed-effects model, age was not significantly interactive with BMD at the lumbar spine (P = 0.23), femoral neck (P = 0.59), total hip (P = 0.93), and distal radius (P = 0.90). However, there was a significant interaction with age and TBS in the entire cohort (P = 0.01). When stratified by age 50, the values for TBS at baseline and 6, 12, 18, and 24 months were significantly higher in the younger group than the older group. In addition, older nonobese had significantly higher TBS values than the older obese subgroup across all time points.
Changes in bone turnover markers and the relationship with BMD and TBS Both markers of bone resorption (CTX) and bone formation (P1NP) are significantly reduced postparathyroidectomy. There is no difference in the bone formation marker P1NP between the obese and nonobese group across the 2 years of observation (Fig. 3) . Moreover, there was no difference in the bone resorption marker CTX at the 6-and 18-month time points between the obese and nonobese group. However, at month 12, the obese subjects had a transiently larger decrease in CTX (absolute difference 233.7 6 14.7%; P = 0.02) and at month 24 (absolute difference 230.8 6 15.3%; P = 0.048) compared with the nonobese group (Fig. 4) .
BMD: lumbar spine
With the exception of the 6-month postparathyroidectomy time point, changes in CTX were negatively correlated with changes in lumbar spine BMD (12 months: r = 20.413, P = 0.05; 18 months, r = 20.511, P = 0.03; and 24 months: r = 20.548, P = 0.02). The correlation between lumbar spine BMD and the bone formation marker P1NP was not as consistent, with significant changes only being seen at 18 months (r = 20.570; P = 0.01) and 24 months (r = 20.541; P = 0.02).
BMD: total hip
In the relationship between total hip BMD and CTX, there was a 6-month displacement in time with the change in total hip BMD occurring 6 months after the change in CTX: 6-month CTX vs 12-month total hip BMD (r = 20.439; P = 0.047); 12-month CTX vs 18-month total hip BMD (r = 20.556; P = 0.02); and 18-month CTX vs 24-month total hip BMD (r = 20.630; P = 0.007). For P1NP, the only time point that was correlated with a change in total hip BMD was at 18 months (r = 20.461; P = 0.047).
BMD: femoral neck
Similar to the relationship between CTX and total hip BMD, the relationship between the change in CTX and femoral neck BMD correlated significantly at each time point but was displaced in time by 6 months: 6-month CTX vs 12-month femoral neck BMD: r = 20.594, P = 0.005; 12-month CTX vs 18-month femoral neck BMD: r = 20.534, P = 0.023; and 18-month CTX vs 24-month femoral neck BMD at 24 months: r = 20.502, P = 0.04. For P1NP, the only time point that was correlated with a change in femoral neck BMD was 6 months: r = 20.473; P = 0.03.
BMD distal radius
There was no noteworthy correlation between changes in bone turnover markers and changes at the distal onethird radius BMD site at any time points at baseline or postparathyroidectomy.
TBS
There was no notable correlation between bone turnover markers and TBS at any time points at baseline or postparathyroidectomy.
Discussion
Our results demonstrate the detrimental effect of obesity on TBS, a clinically useful index of bone quality, in subjects with PHPT. By TBS, obese subjects showed evidence of fully degraded trabecular microarchitecture, despite similar values in BMD by DXA compared with nonobese subjects. Following successful parathyroid surgery, obese subjects had persistently low TBS at 24 months despite improvement in BMD at the lumbar spine and femoral neck. In the nonobese subjects, TBS was only minimally reduced at baseline and persisted at this level throughout the 24-month post-parathyroid surgery period. Similarly, nonobese subjects had an improvement in BMD at the lumbar spine and femoral neck even though TBS values remained unchanged. Additionally, although the magnitude of increase was similar, there was a notable 6-month delay in BMD improvement among the obese as compared with the nonobese at the lumbar spine and femoral neck but not at the total hip and distal radius.
Few studies have used TBS as a clinical index of bone quality in PHPT. In a cross-sectional study of 22 postmenopausal women from our group, we showed a discordance between TBS and BMD, demonstrating that TBS identified more patients with osteoporosis or osteopenia than did lumbar spine BMD (13) . In this prospective study, we further show the negative influence of adiposity on TBS. Even with lumbar spine BMD relatively preserved in both the obese and nonobese subjects, TBS was discordant and considerably lower in the obese participants. Longitudinal studies with TBS in PHPT are limited. In a small cohort of 20 Italian subjects undergoing parathyroidectomy, TBS Z-scores improved significantly from 23.03 6 1.17 to 21.63 6 0.37 at 2 years (9). In contrast, we did not observe an improvement in TBS values after parathyroidectomy in our cohort as a whole as well as the obese and nonobese subgroups. Potential reasons for these differences among the two studies include differences in the characteristics of the study populations. The Italian cohort had more severe biochemical PHPT with lower 25-hydroxyvitamin D levels, higher PTH levels, and worse areal bone densities at the spine and hip. Of note, the BMD Z-scores at the lumbar spine and femoral neck in the Italian cohort were ;1 SD below the values in our cohort. The baseline TBS Z-score in the Italian cohort (with reference to French normative data) was 23.03 6 1.17, whereas the baseline absolute TBS in this study was 1.287 6 0.111, which corresponds to at most 1 SD away from the same French reference cohort and ;2 SDs higher than the Italian cohort (16) .
The difference between the rapid improvements in BMD in both obese and nonobese subjects and the lack of any change by TBS after parathroidectomy is noteworthy in this cohort of subjects with relatively mild PHPT. This observation could well reflect the point that changes in skeletal microstructure, as detected by TBS, may take longer to be demonstrable than simple improvement in bone mineral content. The ability to see this difference in kinetics of change over time may be a particular feature of the mild PHPT state that allowed us to make this observation. It is reasonable to expect that longer follow-up will eventually show an improvement in TBS scores, but whether the time course of this change will be different between the obese and nonobese subjects remains to be seen.
Novel imaging techniques have dispelled the notion that trabecular sites are preserved in mild asymptomatic PHPT when evaluated by DXA. Studies employing highresolution peripheral qualitative computed tomography show that both cortical as well as trabecular microarchitecture are detrimentally affected (17, 18) . Our results as well as those from previous studies demonstrate that TBS is low in patients with mild asymptomatic disease (10, 13) . Even when derived from the lumbar spine, a site that is conventionally regarded as a trabecular site, it must be noted that TBS does not only indirectly reflect the trabecular microstructure but rather indirectly reflects a composite of both cortical as well as trabecular microstructure. Silva et al. (13) have shown that TBS correlated with all cortical and trabecular highresolution peripheral qualitative computed tomography indices except for trabecular thickness and trabecular stiffness at the radius and with similar findings at the weight-bearing tibia after adjusting for weight. Although a direct association between BMI and BMD is well documented (19) (20) (21) , and an association between low BMI and increased fracture risk is clearly established (22) , the relationship between adiposity and fracture risk is less clear. The high prevalence of obesity in postmenopausal women with fragility fractures does not support the notion that adiposity is protective against fractures (23) . One study demonstrated that after adjusting for the mechanical loading effect of body weight on the skeleton, there was an inverse relationship between fat mass and bone mass (24) . In a meta-analysis of multiple prospective populationbased cohorts, the relationship between BMI and fracture risk was nonlinear, with a marked increase in risk for the underweight and a modest decrease in the obese (25) . However, studies have not consistently shown a lower overall fracture risk, with some studies showing an increase in fractures associated with obesity that may be site-specific (26) (27) (28) (29) (30) .
The influence of adiposity on skeletal microarchitecture may be dependent on fat distribution. The type of fat distribution, whether gynoid or android, can influence the direction of the relationship between TBS and obesity. In men, there is an inverse relationship between TBS and BMI (r = 20.452; P , 0.0001) (31) . This relationship is not as clear in women, however. Some studies reported the same inverse association in women (32) (33) (34) , although conflicting results were noted in a study of postmenopausal women from Korea (35) . In that study, TBS was instead positively related to BMI (r = 0.099; P , 0.001), and the investigators further showed that TBS was positively associated with gynoid fat mass (r = 0.086; P , 0.05) but negatively related to android fat mass (r = 20.106; P , 0.05). Likewise, other studies have confirmed that android fat distribution or visceral fat is detrimental to bone health (36, 37) . As it has been previously shown that postmenopausal women with PHPT had a more android pattern of fat distribution than age-matched controls (38), the inverse relationship seen in our study may be consistent with existing evidence, although we did not classify subjects by fat distribution in this study.
As adipocytes and osteoblasts originate from the same pluripotent mesenchymal stem cells, PTH may have a complex role in energy homeostasis through its effect on adipocyte differentiation and by influencing the process of adipogenesis (39) . PTH can direct the mesenchymal stem cell toward the osteoblast lineage and away from adiopogenesis (11) . Given that PTH has dual anabolic and catabolic effects depending on its interaction with different states of the PTH/PTH-related protein receptor, it is plausible that the direction of the mesenchymal stem cell fate may differ with chronic exposure to excessive PTH as in PHPT (40) . An increase in bone marrow adipocytes has been shown to reflect a worsened skeletal microarchitecture in aging and osteoporosis as well as in other diseases (41) (42) (43) . This detrimental effect on skeletal microarchitecture may possibly be compounded by obesity (39, 44) .
We also note the observation that the vitamin D levels were similar between the obese and nonobese subjects. This is likely because most of the subjects (76.7%) were on vitamin D supplementation. We did not note any difference in the proportion of vitamin D supplement users between the obese (80%) and nonobese groups (75%) (P = 0.760). Similarly, there was no difference in the median weekly dosage of vitamin D supplementation between the obese [7000 (5250 to 13,575 IU/ week)] and nonobese [5000 (0 to 14,000 IU/week)] groups (P = 0.327). The interesting normalization of 25-hydroxyvitamin D levels in patients with modern-day PHPT has previously been reported by Walker et al. (45) In that cohort, a majority of subjects were taking vitamin D supplements. Our study, however, makes this observation among both obese and nonobese cohorts with PHPT.
We recently reported substantial reductions in bone turnover markers postparathyroidectomy (46) . Although obesity has been associated with a global suppression of bone turnover in patients without PHPT (47, 48), we did not detect any difference in the bone formation marker P1NP between the obese and nonobese group across the 2 years of observation, except for bone resorption marker CTX, demonstrating a transiently larger decrease at 12 and 24 months in patients with PHPT. The decrease in CTX has been related to improvement in areal BMD, consistent with existing data (49) , and has shown that the change in CTX was contemporaneous with the changes in BMD at the spine, whereas there was a 6-month displacement in time with changes in BMD at the hip.
There are several important limitations to this study, most notably the small sample size and a smaller subset of subjects with complete data points (n = 15) over the 2-year observation. In the subanalysis of subjects for whom data were available at all time points, similar robust improvements in BMD contrasting a lack of change in TBS were noted, which substantiates the overall conclusion of the study involving all subjects. We were not able to classify subjects by fat distribution or evaluate the effect of merely being overweight but not obese. There are also concerns that increased soft tissue mass in obese individuals over the vertebrae may artifactually reduce TBS estimates (50) . However, TBS values in our study were calculated using TBS iNsight®, version 2.1 software, with an updated algorithm that adjusts for abdominal soft tissue based on BMI. This system is optimized for BMI within 15 to 37 kg/m 2 , the BMI range of our subjects (51) . There is also no age-, sex-, and weight-matched control population, and comparisons made in the analyses were with subjects' baseline values and between obese and nonobese subjects. The conclusions drawn are thus limited to patients with PHPT who have undergone parathyroidectomy.
